Chief Medical Officer
Bassem joined TFS in 2017 and leads the Medical, Pharmacovigilance, Medical Writing, Regulatory Affairs, Dermatology Centre of Excellence and Real World Evidence teams.
Before joining TFS Bassem held senior medical affairs and leadership positions in several pharmaceutical companies and CROs. He played an integral part in the growth and success of these companies which include ICON, PRA and Premier Research.
Bassem is an experienced Hemato-oncologist and Pharmaceutical Medicine Consultant. He launched his medical career in frontline patient care and has more than a decade of experience in drug development. Bassem has been involved in designing and delivering a high number of haematology/oncology clinical trials, and programs involving many types of therapies including chemotherapies, radiotherapies, targeted therapies, immunotherapies, radio-immunotherapies, gene therapies and GMOs.
Bassem holds an MD, an FFPM and a CCT from the UK Faculty of Pharmaceutical Medicine of the Royal College of Physicians.
Bassem is based in the TFS Office in Uxbridge, UK